Knowledge Management System of Hefei Institute of Physical Science,CAS
Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia | |
Chen, Cheng1,2; Wang, Li1,2,4; Li, Lili3; Wang, Aoli1,3,4![]() ![]() ![]() ![]() ![]() ![]() | |
2020-08-01 | |
发表期刊 | EXPERIMENTAL CELL RESEARCH
![]() |
ISSN | 0014-4827 |
通讯作者 | Xia, Ruixiang(xrx2041@163.com) ; Wang, Wenchao(wwcbox@hmfl.ac.cn) ; Liu, Qingsong(qsliu97@hmfl.ac.cn) |
摘要 | Acute myeloid leukemia (AML) is one of the most common, complex, and heterogeneous hematological malignancies in adults. Despite progresses in understanding the pathology of AML, the 5-year survival rates still remain low compared with CML, CLL, etc. The relationship between genomic features and drug responses is critical for precision medication. Herein, we depicted a picture for response of 145 drugs against 33 primary cell samples derived from AML patients with full spectrum of genomic features assessed by whole exon sequencing and RNA sequencing. In general, most of the samples were much more sensitive to the combinatorial chemotherapy regimens than the single chemotherapy drugs. Overall, these samples were moderately sensitive to the Traditional Chinese Medicine (TCM) and the targeted drugs. In the weighted gene coexpression network analysis (WGCNA), the TCM and targeted therapies displayed similar genetic signatures in the gene module correlation. Meanwhile, the expression of miRNAs, lncRNAs, and mRNAs did not display apparent gene module correlations among those different types of therapies. In addition, the combinatorial chemotherapy bear more module correlations than the single drugs. Interestingly, we found that the gene mutations and drug response were not enriched in any WGCNA module analysis. Most of the sensitive drug response biomarkers were enriched in the ribosome, endocytosis, cell cycle, and p53 associated signaling pathways. This study showed that gene expression modules might show better correlation than gene mutations for drug efficacy predictions. |
关键词 | Acute myeloid leukemia (AML) Drug response Gene mutations |
DOI | 10.1016/j.yexcr.2020.112054 |
关键词[WOS] | ADVANCEMENTS ; EXPRESSION |
收录类别 | SCI |
语种 | 英语 |
资助项目 | National Natural Science Foundation of China[81773777] ; National Natural Science Foundation of China[81673469] ; National Natural Science Foundation of China[81703007] ; Personalized Medicines-Molecular Signature-Based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020114] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China[2018ZX09711002] ; Natural Science Foundation of Anhui Province[1808085QH263] ; Natural Science Foundation of Anhui Province[1908085MH259] ; Higher Education Excellent Youth Foundation by Educational Commission of Anhui Province of China[gxyqZD2017029] ; Key Research and Development Project of Anhui Province[201904a07020057] ; China Postdoctoral Science Foundation[2019M652057] ; Frontier Science Key Research Program of CAS[QYZDB-SSWSLH037] ; CASHIPS Director's Fund[BJPY2019A03] ; Key Program of 13th five-year plan of CASHIPS[KP-201726] ; Presidential Foundation of CASHIPS[YZJJ2018QN17] ; High Magnetic Field Laboratory of Anhui Province |
项目资助者 | National Natural Science Foundation of China ; Personalized Medicines-Molecular Signature-Based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China ; Natural Science Foundation of Anhui Province ; Higher Education Excellent Youth Foundation by Educational Commission of Anhui Province of China ; Key Research and Development Project of Anhui Province ; China Postdoctoral Science Foundation ; Frontier Science Key Research Program of CAS ; CASHIPS Director's Fund ; Key Program of 13th five-year plan of CASHIPS ; Presidential Foundation of CASHIPS ; High Magnetic Field Laboratory of Anhui Province |
WOS研究方向 | Oncology ; Cell Biology |
WOS类目 | Oncology ; Cell Biology |
WOS记录号 | WOS:000539427300004 |
出版者 | ELSEVIER INC |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.hfcas.ac.cn:8080/handle/334002/103020 |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Xia, Ruixiang; Wang, Wenchao; Liu, Qingsong |
作者单位 | 1.Chinese Acad Sci, Hefei Inst Phys Sci, High Magnet Field Lab, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230031, Anhui, Peoples R China 2.Univ Sci & Technol China, Hefei 230036, Anhui, Peoples R China 3.Precis Med Res Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China 4.Chinese Acad Sci, Precis Targeted Therapy Discovery Ctr, Inst Technol Innovat, Hefei Inst Phys Sci, Hefei 230088, Anhui, Peoples R China 5.Anhui Med Univ, Dept Hematol, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China 6.Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China |
推荐引用方式 GB/T 7714 | Chen, Cheng,Wang, Li,Li, Lili,et al. Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia[J]. EXPERIMENTAL CELL RESEARCH,2020,393. |
APA | Chen, Cheng.,Wang, Li.,Li, Lili.,Wang, Aoli.,Huang, Tao.,...&Liu, Qingsong.(2020).Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia.EXPERIMENTAL CELL RESEARCH,393. |
MLA | Chen, Cheng,et al."Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia".EXPERIMENTAL CELL RESEARCH 393(2020). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论